6 Months To Go: CFC Inhaler Phase-Out Deadline Looms
June 5, 2008
With only six months to go until the phase-out of CFC propellants for albuterol inhalers, the FDA notes that up to 55% of inhaler users have still not transitioned to HFA medications. “As respiratory therapists, it’s time to act and make sure our patients are educated and aware of the changes that will occur,” said Tom Kallstrom, Chief Operating Officer of the AARC.
Kallstrom, RRT, AE-C, FAARC, said that that there are several things that respiratory therapists should make sure their patients are aware of as the deadline for total phase-out of CFC inhalers hits on Jan. 1, 2009.
“Make sure patients are aware of this change. Many patients still don’t know about it or understand the differences between CFC and HFA powered inhalers,” said Kallstrom.
Important differences in the inhalers are outlined in a book written by the AARC last year, A Guide to Aerosol Delivery Devices. The distinction between the two types of medications begins on page 18.
Kallstrom offers these tips for respiratory therapists who are interacting with patients:
“As therapists, it’s our obligation to inform and educate with every patient interaction,” said Kallstrom. “If they have questions, we should be the source for their answers.”